Secure Our Care

The U.S. aging population is growing. This #OlderAmericansMonth, let’s remember that seniors, especially those on fixed incomes, rely on affordable medical devices to maintain their independence and age safely at home. Section 232 tariffs could put that access at risk. secureourcare.org/older-american…

As policymakers weigh Section 232 tariffs, medical devices must be exempt to protect seniors’ access to care. At a @DailyCaller event, @sanuzis of @60PlusAssoc warned how 232 tariffs could raise healthcare costs and risk access for those on fixed incomes. secureourcare.org/national-secur…

Every day, American-made medical technology saves lives. Tariffs on critical inputs or finished devices risk raising costs for patients and providers without improving care or strengthening innovation. Patients deserve the best, safest, and highest quality options without disruption.

Take action today! Send a letter to your congressperson – the disability community cannot afford to have more obstacles to equipment that supports their livelihood. secureourcare.org/take-action/

Higher costs on medical devices don’t stay on paper, they reach patients. New tariffs could reduce the availability of essential tools, forcing providers to make difficult choices that impact the quality of care for Americans.

The Section 232 investigation into medical devices risks disrupting access to essential products Americans rely on every day. New tariffs could increase costs, create shortages, and ultimately limit the quality of care for patients nationwide. Read more about this pressing issue at secureourcare.org

Read more here: secureourcare.org/trade-barriers…

From prosthetic limbs to blood collection tubes, medical devices are essential for the care and wellbeing of millions of Americans. New trade barriers and potential tariffs threaten to make these tools unaffordable for those who need them most.

Medicare is America’s promise to our seniors. It should safeguard them from unnecessary hardship later in life, not create more uncertainty about the availability of the best treatment options available. Learn more. secureourcare.org.

.@POTUS seeks to lower drug prices through Medicare, but what about critical cancer testing? Americans deserve quality care they can count on, not inconsistent and unreliable middlemen threatening their access to care.

Studies show that early-stage cancer diagnoses significantly improve survival rates. Limiting test access burdens families emotionally and financially. Click to learn more about the importance of genetic cancer tests. secureourcare.org

Almost 50% of cancer patients can’t afford cancer testing. That’s why Secure Our Care advocates for Medicare coverage of groundbreaking, cost effective cancer diagnostic tests to seniors. Learn more at secureourcare.org

In @PittsburghPG, economist Joseph Mason explains why Medicare coverage for genetic testing is a win for both patients and government efficiency. Click to read more. post-gazette.com/opinion/guest-…

Older Americans deserve more control over their healthcare. Visit our website to learn more about how Medicare Administrative Contractors are standing in the way of patients and their care options. secureourcare.org

One in one thousand Americans aged 60+ are diagnosed with cancer. That’s why diagnostic genetic testing is so important for our seniors. Join us in our fight to protect these tests. secureourcare.org

Medicare Administrative Contractors ending coverage of cancer tests that save lives. We’re advocating for older Americans to have more control over their healthcare and treatment options at secureourcare.org.

“ Crucially, finding a way to eradicate cancers, one of our planet’s most devastating diseases, will be in vain without advancements in diagnostic testing.” Read more from Peter Pitts in @RealClearHealth.. realclearhealth.com/articles/2025/…

The @OIGatHHS’ latest audit claims Medicare Administrative Contractors (MACs) are not performing proper reviews, including inaccuracies in paperwork. oig.hhs.gov/reports/all/20…

In @PittsburghPG, economist Joseph Mason explains why ending Medicare coverage for genetic testing will hurt Pennsylvania. Click to read more. post-gazette.com/opinion/guest-…